(2)The approval periods of the active substances beta-cyfluthrin, chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, indoxacarb, MCPA, MCPB, prosulfocarb and thiophanate-methyl were extended until 31 October 2019 by Commission Implementing Regulation (EU) 2018/1262note.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.